SCHEMBL2710784

SCHEMBL2710784

CCCCCCCCCCCCCCOc1cc(C(=O)O)c(C)c(C(=O)O)c1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 6/20 0.51
S1PR3 Q99500 1/20 0.51
PTPN1 P18031 2/20 0.48
PTPN6 P29350 1/20 0.48
PLA2G2A P14555 1/20 0.48
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46
MEN1 O00255 1/20 0.44
NR1I2 O75469 1/20 0.44
LMNA P02545 1/20 0.44
CHRM2 P08172 1/20 0.44
CYP3A4 P08684 1/20 0.44
ADRA2A P08913 1/20 0.44
MAPT P10636 1/20 0.44
OPRK1 P41145 1/20 0.44
HTR2B P41595 1/20 0.44
SLC6A3 Q01959 1/20 0.44
KMT2A Q03164 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2710840 1.00 PTPN11 (0.51) PTPN11S1PR3PTPN1PTPN6PLA2G2A
SCHEMBL7089930 1.00 PTPN11 (0.51) PTPN11S1PR3PTPN1PTPN6PLA2G2A
SCHEMBL7089886 0.94 TP53 (0.46) PTPN11S1PR3PTPN1PTPN6ALDH1A1
SCHEMBL23748675 0.89 PLA2G2A (0.50) PTPN11S1PR3PTPN1PTPN6PLA2G2A
SCHEMBL9413367 0.83 TSHR (0.38) PTPN11ALDH1A1MEN1KMT2ATSHR
SCHEMBL668981 0.82 PTPN11 (0.64) PTPN11S1PR3PTPN1PTPN6PLA2G2A
SCHEMBL35210991 0.82 PTPN11 (0.64) PTPN11S1PR3PTPN1PTPN6PLA2G2A
SCHEMBL4462194 0.82 PTPN11 (0.64) PTPN11S1PR3PTPN1PTPN6PLA2G2A
SCHEMBL10539639 0.82 PTPN11 (0.64) PTPN11S1PR3PTPN1PTPN6PLA2G2A
SCHEMBL16836639 0.82 PTPN11 (0.60) PTPN11S1PR3PTPN1PTPN6PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8980925-B2 Antimicrobial amphiphiles and methods for their use JAMES MADISON INNOVATIONS, INC. (US) 2015-03-17 US disclosed
US-20140148487-A1 ANTIMICROBIAL AMPHIPHILES AND METHODS FOR THEIR USE James Madison Innovations, Inc, (US) 2014-05-29 US disclosed
WO-2012054695-A1 NTIMICROBIAL AMPHIPHILES AND METHODS FOR THEIR USE JAMES MADISON INNOVATIONS, INC. (US) 2012-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140148487-A1 ANTIMICROBIAL AMPHIPHILES AND METHODS FOR THEIR USE ANXA5, ANXA4, ANXA6 PTPN11 4424/4885S1PR3 963/4885PTPN1 4272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.